Zvonimir Krajcer, MD

Dr. Krajcer is an interventional cardiologist at The Texas Heart Institute Center for Cardiovascular Care and a member of Texas Heart Institute’s Professional Staff. He is an active member of the Texas Heart Institute Cardiovascular Disease Fellowship Program at Baylor St. Luke’s Medical Center teaching staff, training our next generation of physician-scientist and interventional cardiologists. His leadership and commitment to important international research and education collaborations is impacting the care of patients suffering from vascular diseases worldwide. Show full bio

Dr. Krajcer is an internationally recognized pioneer in his field and is the immediate past President of the International Society for Endovascular Specialists dedicated to the advancement of vascular and endovascular therapies.

Since 1996, Dr. Krajcer has participated as a co-investigator and principal investigator in many clinical trials for the treatment of peripheral arterial disease, abdominal and thoracic aortic aneurysms, and carotid artery stenosis including: Corvita AAA trial, Hemobahn Trial, AneuRx AAA Trial, AneuRx Thoracic trial, Wallgraft Trial, Carotid Wallstent Trial, Sapphire Carotid Stent Trial, BEECH Carotid Trial, Sapphire World Registry Trial, Archer Carotid Stent Trial, Choice Carotid stent Trial, Capture I & II Carotid Stent Trials, Endologix EVAR Trials, Valor I and Valor II Trial, Captivia Thoracic Trial, Captivia Acute Dissection Trial, and Excluder Original Design vs. Low Permeability Design study.

 

See Publications

Education

  • Medical School:

    University of Zagreb, Socialist Federal Republic of Yugoslavia, Socialist Republic of Croatia

  • Internship:

    Lutheran Hospital of Milwaukee, Milwaukee, WI

  • Residency:

    Northwestern University, Chicago, IL
    Mercy Hospital and Medical Center

  • Fellowships:

    Passavant Hospital, Wesly Memorial and Lakeside VA Hospital) (Cardiology)

    The Texas Heart Institiute / Baylor College of Medicine/ St. Luke’s Episcopal Hospital (Interventional Cardiology)

Academic & Clinical Affiliations

Certifications

  • American Board of Internal Medicine
  • Certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology

Publications

El Hajj, M. and Krajcer, Z. (2023). The role of transcatheter aortic valve implantation in patients with bicuspid valves in 2023. Tex Heart Inst J 50, e238122. https://doi.org/10.14503/THIJ-23-8122.
El Hajj, M. and Krajcer, Z. (2023). Bioresorbable stents: We have more work to do. Catheter Cardiovasc Interv 101, 978–979. https://doi.org/10.1002/ccd.30621.
Postalian, A. and Krajcer, Z. (2023). The relationship between chronic kidney disease and “complex” percutaneous coronary intervention: Uncovering the details. Catheter Cardiovasc Interv 101, 949–950. https://doi.org/10.1002/ccd.30612.
El Hajj, M. and Krajcer, Z. (2023). A roadmap to arrhythmias after transcatheter pulmonary valve replacement in pediatric patients. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.30586.
Krajcer, Z. (2023). The Texas Heart Institute Journal at 50 Years: Upholding Our Vision. Tex Heart Inst J 50, e238106. https://doi.org/10.14503/THIJ-23-8106.
El Hajj, M. and Krajcer, Z. (2022). Percutaneous tricuspid valve repair: A safer alternative to traditional approaches? Catheter Cardiovasc Interv 100, 1300–1301. https://doi.org/10.1002/ccd.30497.
Postalian, A. and Krajcer, Z. (2022). Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention. Catheter Cardiovasc Interv 99, 1817–1818. https://doi.org/10.1002/ccd.30216.
Segar, M. W. and Krajcer, Z. (2022). Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap. Catheter Cardiovasc Interv 99, 1645–1646. https://doi.org/10.1002/ccd.30196.
Krajcer, Z. (2022). Artificial intelligence in cardiovascular medicine: Historical overview, current status, and future directions. Tex Heart Inst J 49, e207527. https://doi.org/10.14503/THIJ-20-7527.
Krajcer, Z. (2022). Artificial intelligence for education, proctoring, and credentialing in cardiovascular medicine. Tex Heart Inst J 49, e217572. https://doi.org/10.14503/THIJ-21-7572.

Recent News

The Texas Heart Institute Journal Accepted into Directory of Open Access Journals (DOAJ) Index

The Texas Heart Institute Journal has recently been accepted into the prestigious Directory of Open Access Journals (DOAJ) index, which...

Drs. Matthew Segar and Milos Matkovic Honored With 2023 James T. Willerson, MD, Editor’s Choice Awards

Houston, Texas – March 1, 2024 – The Texas Heart Institute presented the 2023 James T. Willerson, MD, Editor’s Choice...

Dr. Krajcer awarded the Award for Excellence in Academics at 4TS in Dubai

Top to Toe Transcatheter Solutions Conference 2024 (4TS 2024) was a momentous event that marked a decade of groundbreaking achievements...